Trials / Completed
CompletedNCT04777929
The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Phthalates are a group of ubiquitous synthetic endocrine-disrupting chemicals. Fetal and neonatal periods are particularly susceptible to endocrine disorders, which prenatal exposure to phthalates causes. There is increasing evidence concerning the potential endocrine disrupting for phthalate exposure during pregnancy. Prenatal exposure phthalates would disrupt the level of sex hormone in pregnant women, which results in preeclampsia. The relationship of prenatal phthalate exposure with maternal and neonatal outcomes in human beings was often sex-specific associations. Because of the potentially harmful influence of prenatal phthalate exposure, steps should be taken to prevent or reduce phthalate exposure during pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | test Phthalates, estrogen and progesterone | test mothers Phthalates in their urine, and test estrogen and progesterone receptor in placental tissue |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-09-30
- Completion
- 2022-10-31
- First posted
- 2021-03-02
- Last updated
- 2022-11-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04777929. Inclusion in this directory is not an endorsement.